| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T93 |
0-64 |
Sentence |
denotes |
Table 1 CC50 and EC50 and Therapeutic Indexes of Lead Compounds |
| T94 |
65-104 |
Sentence |
denotes |
quantal dose–response relationship (μM) |
| T95 |
105-144 |
Sentence |
denotes |
compound CC50a EC50b TIc (CC50/EC50) |
| T96 |
145-166 |
Sentence |
denotes |
P1 459.69 >100 NAd |
| T97 |
167-188 |
Sentence |
denotes |
P2 569.77 >100 NAd |
| T98 |
189-211 |
Sentence |
denotes |
P3 805.32 32.1 25.1 |
| T99 |
212-220 |
Sentence |
denotes |
a CC50: |
| T100 |
221-257 |
Sentence |
denotes |
Half maximal toxicity concentration. |
| T101 |
258-266 |
Sentence |
denotes |
b EC50: |
| T102 |
267-304 |
Sentence |
denotes |
Half maximum effective concentration. |
| T103 |
305-311 |
Sentence |
denotes |
c TI: |
| T104 |
312-330 |
Sentence |
denotes |
Therapeutic index. |
| T105 |
331-337 |
Sentence |
denotes |
d NA: |
| T106 |
338-351 |
Sentence |
denotes |
Nonavailable. |
